Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949879 · ClinicalTrials.gov registry record · NA
Dose Response Effects of Pecan Consumption
A NA study of Overweight and Obesity and Nutrition, Healthy, sponsored by University of Georgia.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05949879 is a NA study of Overweight and Obesity and Nutrition, Healthy that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 80 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05949879, a NA study of Overweight and Obesity and Nutrition, Healthy, is actively recruiting participants, sponsored by University of Georgia.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, folic acid, calcium, magnesium, phosphorus, potassium, and zinc. These bioactive components in pecans are likely the reason for the previously documented improvements in cardiometabolic health. The specific aims of this study are to: * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on fasting and postprandial blood lipids. * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on plasma markers associated with overall health. * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on subjective and physiologic postprandial measures of hunger and satiety. Participants will be asked to: * Consume pecans daily for 28 days or maintain their current habitual diet. * Attend three short weekly visits for fasting blood craws, body measurements, and collect their next week's supply of study materials. * Attend two longer (5 h) testing visits which include consuming a standard breakfast meal and having their blood drawn periodically before and after breakfast. Researchers will compare pecan LOW, pecan MID, pecan HIGH, and the Control group to examine the physiologic effects of incorporating various dosages of pecans into one's diet.
Conditions Studied
Interventions
- OTHER Pecan LOW
- OTHER Pecan MID
- OTHER Pecan HIGH
- OTHER CONTROL
Study Locations (1)
Georgia
- University of Georgia - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05949879
The ClinicalTrials.gov registry entry for NCT05949879 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (65% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 4 interventions - of which Pecan LOW is the first listed.
NCT05949879 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05949879 about?
NCT05949879 is a clinical study titled "Dose Response Effects of Pecan Consumption". The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, ...
What is the current status of trial NCT05949879?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-08-01. Estimated completion is 2026-08-01.
What conditions does trial NCT05949879 study?
This clinical trial studies the following conditions: Overweight and Obesity, Nutrition, Healthy, Dyslipidemias.
What interventions are being tested in trial NCT05949879?
The interventions under investigation include: Pecan LOW (OTHER), Pecan MID (OTHER), Pecan HIGH (OTHER), CONTROL (OTHER).
Who is sponsoring clinical trial NCT05949879?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05949879 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Effects of Watermelon or Low-fat Cookie Consumption on Wellness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.